ARCHIVES

FDA Forms Office of Combination Products;

This article is from The Cancer Letter archive.

Vol. 29 No. 02 | January 10, 2003

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Risk Prediction Improved In Atypia Cases

July 27, 2007

NCI Advised To Seek Greater Local Contribution to Construction Projects; Other changes Asked

January 28, 1977

FDA cancer therapeutics review split among three units in reorganization.

October 10, 2003

Phase III Tumor Treating Fields Trial Halted Following Positive Results in Interim Analysis

November 28, 2014

Advisors Recommend Listing Estrogen As Carcinogen.

January 12, 2001

ASCO Updates Guideline On Use Of Tumor Markers

October 27, 2006